Moderna, Inc. (MRNA)
138.82
-6.31
(-4.35%)
USD |
NASDAQ |
Aug 24, 16:00
138.95
+0.13
(+0.09%)
After-Hours: 19:56
Moderna Price to Book Value : 8.192 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 8.565 |
| August 20, 2026 | 7.868 |
| August 19, 2026 | 10.29 |
| August 18, 2026 | 3.716 |
| August 17, 2026 | 3.804 |
| August 14, 2026 | 3.737 |
| August 13, 2026 | 3.756 |
| August 12, 2026 | 3.758 |
| August 11, 2026 | 3.574 |
| August 10, 2026 | 3.530 |
| August 07, 2026 | 3.492 |
| August 06, 2026 | 3.178 |
| August 05, 2026 | 3.320 |
| August 04, 2026 | 3.363 |
| August 03, 2026 | 3.254 |
| July 31, 2026 | 3.235 |
| July 30, 2026 | 3.418 |
| July 29, 2026 | 3.216 |
| July 28, 2026 | 3.293 |
| July 27, 2026 | 3.283 |
| July 24, 2026 | 3.191 |
| July 23, 2026 | 3.365 |
| July 22, 2026 | 3.427 |
| July 21, 2026 | 3.521 |
| July 20, 2026 | 3.511 |
| Date | Value |
|---|---|
| July 17, 2026 | 3.648 |
| July 16, 2026 | 3.727 |
| July 15, 2026 | 4.030 |
| July 14, 2026 | 3.98 |
| July 13, 2026 | 3.955 |
| July 10, 2026 | 4.029 |
| July 09, 2026 | 4.518 |
| July 08, 2026 | 4.355 |
| July 07, 2026 | 4.708 |
| July 06, 2026 | 4.827 |
| July 02, 2026 | 4.707 |
| July 01, 2026 | 4.279 |
| June 30, 2026 | 4.133 |
| June 29, 2026 | 3.735 |
| June 26, 2026 | 3.605 |
| June 25, 2026 | 3.202 |
| June 24, 2026 | 3.238 |
| June 23, 2026 | 3.269 |
| June 22, 2026 | 3.180 |
| June 18, 2026 | 3.428 |
| June 17, 2026 | 3.312 |
| June 16, 2026 | 2.969 |
| June 15, 2026 | 2.794 |
| June 12, 2026 | 2.675 |
| June 11, 2026 | 2.660 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| BioNTech SE | 1.396 |
| Kailera Therapeutics, Inc. | 1.917 |
| Sarepta Therapeutics, Inc. | 1.253 |
| Replimune Group, Inc. | 11.68 |
| Intellia Therapeutics, Inc. | 2.415 |
Price to Book Value Related Metrics
| PS Ratio | 24.53 |
| PEG Ratio | -2.803 |
| Price | 138.82 |
| Earnings Yield | -5.75% |
| Market Cap | 55.39B |
| PEGY Ratio | -2.803 |